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Abstract
A link between circadian rhythm and metabolism has long been discussed. Circadian rhythm is controlled by positive and
negative transcriptional and translational feedback loops composed of several clock genes. Among clock genes, the brain
and muscle Arnt-like protein-1 (BMAL1) and circadian locomotor output cycles kaput (CLOCK) play important roles in the
regulation of the positive rhythmic transcription. In addition to control of circadian rhythm, we have previously shown that
BMAL1 regulates adipogenesis. In metabolic syndrome patients, the function of BMAL1 is dysregulated in visceral adipose
tissue. In addition, analysis of SNPs has revealed that BMAL1 is associated with susceptibility to hypertension and type II
diabetes. Furthermore, the significant roles of BMAL1 in pancreatic b cells proliferation and maturation were recently
reported. These results suggest that BMAL1 regulates energy homeostasis. Therefore, in this study, we examined whether
loss of BMAL1 function is capable of inducing metabolic syndrome. Deficient of the Bmal1 gene in mice resulted in elevation
of the respiratory quotient value, indicating that BMAL1 is involved in the utilization of fat as an energy source. Indeed, lack
of Bmal1 reduced the capacity of fat storage in adipose tissue, resulting in an increase in the levels of circulating fatty acids,
including triglycerides, free fatty acids, and cholesterol. Elevation of the circulating fatty acids level induced the formation of
ectopic fat in the liver and skeletal muscle in Bmal1 -/- mice. Interestingly, ectopic fat formation was not observed in tissue-
specific (liver or skeletal muscle) Bmal1 -/- mice even under high fat diet feeding condition. Therefore, we were led to
conclude that BMAL1 is a crucial factor in the regulation of energy homeostasis, and disorders of the functions of BMAL1
lead to the development of metabolic syndrome.
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Introduction
In recent years, the metabolic syndrome has become increas-
ingly prevalent with major public consequences. Various lifestyle
changes compared with a few decades ago are suspected to be the
cause of the rapid increase in the number of metabolic syndrome
patients. These changes include excessive energy intake from lipid-
based foods, late dinners, reduced sleeping time, lack of exercise,
excessive stress, etc. In addition to these factors, there is
accumulating epidemiological evidence that shift work increases
the risk of metabolic syndrome [1–4]. Tenkanen et al. reported
that, in Finland, when all shift workers were compared with all day
workers, the relative risk for ischemic heart disease was 1.4-fold
greater in the former after adjustment for lifestyle factors, blood
pressure, and serum lipid levels [1]. Similarly, the Nurses’ Health
Study in the United States reported that the multivariate-adjusted
relative risks for ischemic heart disease were 1.51-fold higher
among women reporting 6 or more years of rotating night shifts,
compared with women who had never done shift work [2].
Karlsson et al. reported that high triglycerides (TG) and low
concentrations of high-density lipoprotein (HDL) cholesterol seem
to cluster together more often in shift workers than in day workers
[3]. A large-scale prospective cohort study in Japanese workers
showed that,compared withdayworkers,rotating-shift workers had
a significantly higher risk of death due to ischemic heart disease,
whereas fixed-night work was not associated with ischemic heart
disease or obesity [4].
The mechanism by which shift work increases metabolic
syndrome onset risk is not clear, but it is speculated that shift
work has an influence on the circadian rhythms of physiologic
functions such as blood pressure, heart rate, and the secretion and
excretion of hormones, etc. [5–11]. The machinery of circadian
rhythm has been conserved throughout evolution. In the
regulation of circadian rhythms, two transcription factors, the
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MOP3 or Arnt3) and circadian locomotor output cycles kaput
(CLOCK), play central roles [12–15]. BMAL1 and CLOCK form
a heterodimer and drive transcription from E-box elements found
in the promoters of circadian-responsive genes, including period
(Per) 1 and cryptochrome (Cry). After translation of the Per and Cry
proteins, the Per/Cry complex translocates to the nucleus, where it
inhibits gene expression driven by BMAL1 and CLOCK [16–19].
In addition to its roles in the control of circadian rhythms,
BMAL1 has been suggested to contribute to the regulation of
metabolism for the following reasons. First, genome-wide profiling
of BMAL1 targets revealed their strict relationship with metab-
olism [20]. Second, SNP analysis revealed that BMAL1 is
associated with type II diabetes and hypertension [21]. In
addition, BMAL1 is strongly induced during adipogenesis and
regulates adipocyte functions [22]. BMAL1 activity is disturbed in
the visceral adipose tissue of metabolic syndrome patients [23,24].
A recent study revealed that BMAL1 and CLOCK play critical
roles in proliferation and functions of pancreatic b cells [25]. In
addition, Hemmeryckx et al. reported that lack of Bmal1 increases
the arterial and venous thrombosis [26]. In regard to food intake,
Bmal1-deficient (-/-) mice show robust food anticipatory activity
[27]. Moreover, mice carrying mutation in the Clock gene are
obese and develop a metabolic syndrome consisting of hyperlepti-
nemia, hyperlipidemia, and hyperglycemia [28]. These results
suggest that loss of functions of BMAL1 may lead to the
development of metabolic syndrome.
We show here that global (whole body) Bmal1 -/- mice, derived
from the embryonic stem (ES) cells of C57BL/6J mice, exhibited a
metabolic syndrome-like onset, i.e., elevation of the level of
circulating fatty acids, including TG, free fatty acids, and low-
density lipoprotein (LDL)-cholesterol. In addition, ectopic fat
formation was observed in the liver and skeletal muscle. The
mechanism of these effects may involve loss of the functions of
adipose tissue, since ectopic fat formation was not observed in
tissue-specific (liver or skeletal muscle) Bmal1 -/- mice even under
high fat diet feeding condition. Consequently, we are led to
conclude that BMAL1 plays crucial roles in the control of energy
homeostasis.
Results
Loss of the Bmal1 gene results in an increase of the
respiratory quotient (RQ)
In this study, we first generated conditional Bmal1 (flox/flox)
mice carrying the conditional Bmal1 allele containing exons 6 to 8
flanked by loxP sites (Fig. S1 and S2). Since genetic background-
specific phenotypes were observed in Clock-mutant mice [28,29],
conditional Bmal1 (flox/flox) mice were obtained using ES cells
derived from C57BL/6J mice, and the genetic background of the
mice was maintained on C57BL/6J. These mice are useful to
generate both global- and tissue-specific mice. In all experiments,
littermate mice were used as a ‘‘control’’. Similar to the Mop3 -/-
mice established previously [14], the Bmal1 -/- mice exhibited loss
of circadian rhythm in locomotor activity (Fig. S3). In contrast,
locomotor activity of liver-specific (L-) Bmal1 -/- mice and skeletal
muscle-specific Bmal1 -/- mice showed no significant differences
with that of control mice (Fig. S3).
To characterize the metabolic activity of the Bmal1 -/- mice, in
a first set of experiments, the respiratory quotient (RQ) was
determined. Mice were housed in a chamber connected to indirect
calorimeter under a light/dark (12 h/12 h) condition (LD) or
constant darkness condition (DD). To obtain RQ, the amount of
CO2 eliminated from the body and the amount of O2 consumed
were measured. As shown in Fig. 1, the daily value of the RQ in
the Bmal1 -/- mice was greater than that in control mice under
both the LD condition and DD condition.
High-fat diet increases circulating fatty acids level and
ectopic fat accumulation in Bmal1 -/- mice
The higher RQ value in Bmal1 -/- mice compared with control
mice suggested lower utilization of fat as an energy source in Bmal1
-/- mice (Fig. 1). To confirm this, Bmal1 -/- mice were subjected to
a high-fat diet challenge. As reported previously [30], the body
weight of Bmal1 -/- mice was lighter than that of control mice
under a regular diet condition (Fig. 2A). Feeding with a high-fat
diet induced body-weight gain in both control mice and Bmal1 -/-
mice (Fig. 2A). However, while the body weight of control mice
continuously increased during the challenge, that of Bmal1 -/-
mice remained almost constant after 4 weeks of the challenge
(Fig. 2A). There were no substantial differences in the calorie
intake of control mice and Bmal1 -/- mice during the challenge
(Fig. 2B). After 5 weeks of the high-fat diet challenge, the adipose
tissue mass in Bmal1 -/- mice was smaller than that in control mice
(Fig. 3A). Also, a histological study showed that the size of
adipocytes in Bmal1 -/- mice was smaller than that in control mice
(Fig. 3B and C). As summarized in Fig. 4 and Fig. S4, gene
expression of adipogenesis-related transcription factors and a series
of factors responsible for synthesis of TG and fatty acids were
substantially decreased in adipose tissue in Bmal1 -/- mice.
Furthermore, a significant decrease in the expression of factors
involved in fat burning, such as Ucp3 and b3 adrenalin receptor, was
Figure 1. Abnormal respiration activity in Bmal1 -/- mice. (A) The respiratory quotient (RQ) of male mice housed under the light/dark condition
(LD) or constant darkness condition (DD) was determined by indirect calorimeter. The daily average of RQ corrected by body weight was calculated.
Data represent the means 6 SEM (n=6 for each genotype). Asterisks indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0025231.g001
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marker gene for preadipocytes, was highly expressed in adipose
tissue in Bmal1 -/- mice (Fig. 4).
In the next set of experiments, several biochemical markers
were determined. The level of serum TG in Bmal1 -/- mice was
higher than that in control mice under the regular-diet feeding
condition, and the difference was further pronounced in mice fed a
high-fat diet (Fig. 5A). Also, the level of serum NEFA and
cholesterol in Bmal1 -/- mice became higher than that in control
mice by feeding a high-fat diet (Fig. 5B and C). Detailed profiling
of the cholesterol content in the lipoprotein fractions revealed an
increase of the cholesterol level in chylomicron (CM), very low
Figure 2. Effects of a high-fat diet feeding on the body weight. (A) Male control mice and Bmal1 -/- mice were subjected to a high-fat diet
(HFD) challenge at 6 weeks of age. The body weights of the mice fed either a regular diet (RD) or HFD were determined. Data represent the means 6
SEM (n=8 for each genotype). Asterisks indicate significant differences (P,0.05). (B) The daily average of the calorie intake of male mice at 11 weeks
of age (5 weeks with a HFD) was determined. Data represent the means 6 SEM (n=8 for each genotype and treatment).
doi:10.1371/journal.pone.0025231.g002
Figure 3. Effects of a high-fat diet feeding on histology of adipocytes in Bmal1 -/- mice. Adipose tissue was excised at zeitgeber time (ZT)
10. (A) Representative morphology of adipose tissue in control mice and Bmal1 -/- mice fed a HFD for 5 weeks. (B) Representative HE staining of
epididymal white adipose tissue isolated from male control mice and Bmal1 -/- mice fed a HFD for 5 weeks. Scale bars indicate 100 mm. (C) Average
cross-sectional area of individual adipocytes in control mice and Bmal1 -/- mice fed a HFD. Data represent the means 6 SEM (n=5 for each
genotype). Asterisks indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0025231.g003
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Bmal1 -/- mice fed a regular diet (Table 1). Calculation of the TG/
cholesterol molar ratio revealed a reduction in the relative content
of TG in the lipoprotein complex in Bmal1 -/- mice (Table 2). The
LDL cholesterol/HDL cholesterol ratio, a potent marker for risk
of arteriosclerosis, in Bmal1 -/- mice was remarkably greater than
that in control mice (Fig. 5D).
High fat diet feeding induced fatty liver in Bmal1 -/- mice but
not in control mice (Fig. 6A and B). Quantification of tissue TG
content revealed significant accumulation of TG in the liver and
skeletal muscle in Bmal1 -/- mice (Fig. 6C and D). Interestingly,
under both normal diet and high fat diet conditions, TG contents
in the liver in liver-specific (L-) Bmal1 -/- mice and the skeletal
muscle in skeletal muscle-specific (M-) Bmal1 -/- mice were almost
equal to those in control mice (Fig. 6C and D).
Loss of the Bmal1 gene alters the expression level of
metabolism-related genes
To gain insight into the ectopic fat accumulation in Bmal1 -/-
mice, gene expression in the liver and muscle was compared to
Figure 4. Comparison of gene expressions in adipose tissues. Gene expressions in adipose tissues in control mice and Bmal1 -/- mice at ZT10
and 22 were determined by RT-qPCR. Relative mRNA levels were normalized to the 36B4 level. Data represents the means 6 SEM (n=5 for each
genotype and point). Asterisks indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0025231.g004
Figure 5. Alteration of circulating fatty acids level in Bmal1 -/- mice. Serum samples were prepared from male mice fed a regular diet (RD) or
a high-fat diet (HFD) for 5 weeks. All samples were collected at ZT 10. (A) Triglycerides (TG). (B) Non-esterified fatty acids (NEFA). (C) Total cholesterol.
Data represent the means 6 SEM (n=8 for each genotype and treatment). Asterisks indicate significant differences (P,0.05). (D) The LDL cholesterol/
HDL cholesterol ratio was calculated based on the data shown in Table 1. Data represent the means 6 SEM (n=8 for each genotype and treatment).
Asterisks indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0025231.g005
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selected lipid metabolism-related genes are summarized in Table 3
and S1. In the Bmal1 -/- mice liver, a robust (,78-fold) increase in
Lpl expression was observed (Table 3). This increased expression
of Lpl gene was also observed in the liver in L-Bmal1 -/- mice
(Fig. 7A and D) and in the Bmal1 knockdown cultured hepatocytes
prepared from control mice (Fig. S5). The expression pattern of
Lpl showed clear circadian oscillations in the liver of control mice
under both the LD and DD condition (Fig. 7B–D). The expression
of genes involved in fatty acid binding and transport, namely Cd36,
Fabp5, and Srbi, were induced in the Bmal1 -/- mice liver (Table 3).
In the skeletal muscle, the expression of genes in the pathway for de
novo fatty acid synthesis such as Fasn and Scd1, and Agpat3 were
highly induced (Table 3). Conversely, Ldlr expression was
significantly decreased in Bmal1 -/- skeletal muscle (Table 3).
Expression of the Lpl gene in Bmal1 -/- skeletal muscle was not
significantly different compared to that in control mice (Table 3).
In both liver and muscle, expression of genes responsible for
oxidation of fatty acids was decreased (Table 3).
Discussion
A link between circadian rhythm and metabolism has long been
discussed [31,32]. Therefore, in this study, we aimed to study
whether loss of BMAL1 functions induces metabolic syndrome.
Deletion of the Bmal1 gene resulted in an elevation of the daily
average value of the RQ under both the LD and DD conditions
(Fig. 1). An increase in the RQ represents oxidation of
carbohydrates, and a decrease of the value represents oxidation
of fatty acids. Thus, the elevation of RQ in Bmal1 -/- mice
indicates that BMAL1 is involved in the utilization of fat as an
energy source. Indeed, under the high-fat diet challenge, the levels
of circulating fatty acids, including TG, NEFA and cholesterol, in
Bmal1 -/- mice were remarkably increased (Fig. 5A–C). Elevation
of circulating fatty acids induced ectopic fat accumulation in the
liver and muscle (Fig. 6A–D). A detailed profile analysis of the
cholesterol contents in lipoprotein fractions revealed that the ratio
of LDL cholesterol to HDL cholesterol, a potent marker for risk of
arteriosclerosis, in Bmal1 -/- mice was significantly higher than
that in control mice even under a regular-diet condition (Fig. 5D).
Furthermore, Hemmeryckx et al. recently reported endothelial
dysfunction and progression of the prothrombotic state in Bmal1
-/- mice [26]. Consequently, we were led to conclude that the loss
of the Bmal1 gene induced metabolic syndrome.
Ectopic fat formation by high fat feeding was not observed in L-
Bma1 -/- mice and M-Bmal1 -/- mice, suggesting that elevation of
the level of circulating fatty acids level was a main cause of ectopic
fat formation in the tissues. As described above, the RQ value in
Bmal1 -/- mice is higher than that in control mice (Fig. 1). Also,
excess secretion of an oily, waxy substance (sebum) was observed
in Bmal1 -/- mice fed a high-fat diet (Fig. S6). These results suggest
that the ability to utilize and store fat in Bmal1 -/- mice is inferior
to that in control mice. Excess fatty acids are largely deposited in
the adipose tissue. Histological analysis showed that the size of
adipocytes in Bmal1 -/- mice fed a high-fat diet was significantly
smaller than that in control mice (Fig. 3A–C). Since expression of
Ucp3 and b3 adrenalin receptor was down-regulated in the Bmal1 -/-
mice, excess of fatty acid oxidation was unlikely the cause of
decrease of adipocyte size (Fig. S4). As we previously demonstrat-
ed, BMAL1 plays central roles in the regulation of high fat diet-
induced adipogenesis [22]. Indeed, the expression level of the
Pref-1 gene, a marker for preadipocytes, in Bmal1 -/- mice adipose
tissue was greater than that in control mice (Fig. 4). In contrast, the
genes preferentially expressed in mature adipocytes, such as
Pparc2, C/ebpa, and Srebp1c, were expressed at lower levels in
Bmal1 -/- mice (Fig. 4). Furthermore, the expressions of Agpat 2
and lipin were significantly reduced in Bmal1 -/- mice adipose
tissue (Fig. 4). Mutations in Agpat 2 and lipin cause congenital
generalized lipodystrophy [33,34]. As has been demonstrated in
lipodystrophy, the failure of adipose tissue mass to expand and
accommodate a high-energy influx causes accumulation of ectopic
fat [35,36]. Therefore, we are led to conclude that an increase of
the circulating fatty acids level followed by the ectopic fat
accumulation in the Bmal1 -/- mice was mainly due to the
insufficient function of adipose tissue resulting from lower
adipogenesis activity (Fig. 8).
Although both Bmal1 -/- mice and Clock mutant mice develop
metabolic syndrome-like symptoms, Bmal1 -/- mice are thin and
Clock mutant mice are obese (28, 29, this study). As mentioned
above, metabolic disorder in Bmal1 -/- mice was induced as a
result of lower adipogenesis activity, as observed in lipodystrophy.
On the other hand, Clock mutant mice develop metabolic
syndrome-like symptoms presumably as a result of obesity. In
Table 1. Content of cholesterol and triglycerides in lipoproteins.
Cholesterol (mg/dL) Triglyceride (mg/dL)
CM VLDL LDL HDL CM VLDL LDL HDL
RD Control 0.160.0 2.960.2 11.160.1 59.465.8 0.660.1 15.661.4 9.561.1 1.760.2
Bmal1-/- 0.360.0* 7.360.8* 20.560.3* 35.264.8* 4.660.5* 19.462.1 12.761.4* 2.360.2*
HFD Control 0.260.0 5.760.6 25.963.8 123.2620 3.560.4 18.861.9 6.560.7 1.860.1
Bmal1-/- 0.360.0 8.361.0* 128.2614* 184.7623* 5.360.6* 9.161.1* 14.961.8* 3.460.4*
Blood samples were collected at ZT 10. Plasma samples were prepared from male control mice and Bmal1 -/- mice fed either a regular diet (RD) or a high fat diet (HFD)
for 5 weeks. Plasma lipoproteins were separated and analyzed by an on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides by
HPLC. Data represent the means 6 SEM (n=5 for each genotype). Asterisks indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0025231.t001
Table 2. Molar ratio of triglycerides/cholesterol.
CM VLDL LDL HDL
RD Control 2.60 2.36 0.38 0.01
Bmal1-/- 7.76 1.17 0.27 0.03
HFD Control 7.67 1.45 0.11 0.01
Bmal1-/- 7.74 0.48 0.05 0.01
Molar ratio was calculated from the data shown in Table 1. Molecular weights of
882.43 and 386.65 were used for triglycerides and cholesterol, respectively.
doi:10.1371/journal.pone.0025231.t002
Characteristics of Fat Metabolism in Bmal1 KO Mice
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e25231Clock mutant mice, expression level of Bmal1 is significantly
increased [37]. Therefore, one possibility is that BMAL1
overexpressed alone or in cooperation with other genes, such as
Npas2, promotes adipogenesis. Alternatively, BMAL1/mutated
CLOCK complex may act as a dominant negative factor and
affect several gene expression involved in regulation of lipid
metabolism.
Recently, Marcheva et al. reported that BMAL1 and CLOCK
play roles in the regulation of pancreas functions, including the
proliferation of islets and secretion of insulin in response to glucose
[25]. Impaired insulin secretion and glucose intolerance in
Bmal1-/- mice were also observed in this study, as summarized
in Text S1, Fig. S7 and S8. Therefore, one can speculate that the
elevation of circulating fatty acids is partly due to impaired insulin
secretion in Bmal1 -/- mice. Under the condition of the impaired
insulin actions, phosphorylation of Ser residues at 563 and 660 in
hormone sensitive lipase (HSL) in adipose tissue is accelerated,
resulting in increase of lipolysis [38]. In Bmal1-/- mice, despite the
lower insulin secretion, the phosphorylation status of Ser563 and
660 was substantially lower than that in control mice (Fig. S9).
Therefore, although we do not exclude the possibility that, in
Bmal1 -/- mice, impaired insulin secretion is partly responsible for
development of dyslipidemia, its contribution via acceleration of
lipolysis is relatively smaller.
Lack of Bmal1 induced a robust induction of Lpl expression in
the liver (Table 3). A detailed analysis of the lipoprotein complex
revealed that VLDL and LDL in Bmal1 -/- mice were relatively
TG poor (Table 2), suggesting that LPL activity is substantially
increased in Bmal1 -/- mice. This strong induction of Lpl gene
expression was observed in the liver of L-Bmal1 -/- mice, but not in
other tissues, and Bmal1-knockdown cultured hepatocytes (Fig. 7A
and D, Table 3, and Fig. S5). These results indicate that
overexpression of the hepatic Lpl gene was mainly due to the
Figure 6. Ectopic fat accumulation in liver and skeletal muscle in Bmal1 -/- mice. All tissue samples were excised at ZT10. (A) Representative
morphology of the livers from control mice and Bmal1 -/- mice fed a HFD for 5 weeks. (B) Representative oil red O staining of liver tissue samples
isolated from male control mice and Bmal1 -/- mice fed either a RD or HFD for 5 weeks. (C and D) Triglyceride (TG) contents in the liver (C) and skeletal
muscle (D) from male control mice and Bmal1 -/- mice fed a RD or HFD for 5 weeks. Data represent the means 6 SEM (n=8 for each genotype and
treatment). Asterisks indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0025231.g006
Table 3. Gene expressions in Bmal1 -/- mice.
Liver Muscle
ZT10 ZT22 ZT10 ZT22
Fatty acid binding and transpot
Cd36 2.760.3* 1.160.1 1.260.2 1.460.2
Fabp5 4.360.4* 1.560.1* 1.160.1 0.960.2
Ldlr 0.860.3 1.060.2 0.260.1* 0.260.2*
Lpl 77.968.5* 79.369.1* 1.160.2 0.960.1
Srbi 2.760.3* 1.560.1* 0.760.3 1.160.2
TG and fatty acid synthesis
Agat2 0.860.8 0.660.3 1.160.1 1.360.2
Agat3 1.060.2 1.160.1 2.060.2* 1.860.2*
Dgat1 0.660.2* 0.760.1 0.960.2 1.160.1
Dgat2 0.560.1* 0.560.1* 0.660.2* 0.460.2*
Fasn 0.360.0* 0.360.0* 6.360.6* 1.160.2
Scd1 1.360.2 0.360.1* 5.061.1* 2.060.3*
Fatty acid oxidation
Acaa 1a 0.660.1* 0.560.1* 0.860.2 0.760.2
Acaa 1b 0.360.1* 0.260.0* 0.660.3 0.660.3
Acadl 1.760.2 0.760.2 1.660.2* 0.960.2
Acadm 0.760.3 0.760.2 1.760.3* 1.360.1
Echdc1 0.660.1* 0.560.1* 1.360.3 0.960.1
Gene expressions in control mice and Bmal1 -/- mice were determined by RT-
qPCR. Relative mRNA levels were normalized to the 36B4 level. Each value
represented the mean fold-changes (6 SEM) of Bmal1 -/- mice in comparison to
control mice (n=5 for each genotype and point). Asterisks indicate significant
differences (P,0.05).
doi:10.1371/journal.pone.0025231.t003
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specific Lpl transgenic mice demonstrated that overexpression of
the Lpl gene resulted in accumulation of TG in the liver even
under a regular-diet condition [39]. Loss of the Bmal1 gene also
induced Cd36, Fabbp5, and Srbi in the liver (Table 3). Conse-
quently, ectopic fat formation in the liver may be induced by
increased fatty acid transport under the condition of elevated levels
of circulating fatty acids.
Overall, this study showed that BMAL1 activity is closely
associated with lipid metabolism. It is known that several factors
regulating metabolic activity affect Bmal1 functions. One of the
well-characterized examples is the redox state of NAD [40]. The
reduced forms of the redox cofactors, NAD (H) and NADP (H),
strongly enhanced DNA binding of the BMAL1/CLOCK,
whereas the oxidized forms inhibited it [40]. Not only is NAD
important in cellular redox reactions and the DNA-binding
activity of BMAL1/CLOCK, as described above, but it also
serves as a substrate for sirtuin (SIRT) 1, an NAD-dependent and
nutrient-responsive deacetylase [41,42]. SIRT1 activated with
NAD reduces the acetylation status of BMAL1, resulting in the
suppression of BMAL1/CLOCK activity [43]. In diabetic rats
lacking insulin, the phase of the circadian gene expression in the
heart is advanced, suggesting that high blood glucose levels can
phase-shift the clock in peripheral tissues [44]. It has been shown
that ethanol consumption alters the circadian expression pattern of
Per genes [45]. Although it is unknown how ethanol affects the
circadian clock, it may be possible that NADH generated by
alcohol metabolism affects the activity of BMAL1/CLOCK.
In conclusion, the results in this study revealed that loss of the
functions of BMAL1 leads to the development of ectopic fat
Figure 7. Induction of Lpl gene expression in the liver by the deletion of Bmal1 gene. (A) Tissue samples were excised form male control
mice and L-Bmal1 -/- mice at ZT10. The total RNA was extracted from these tissues and the expression of Lpl mRNA was determined by RT-qPCR.
Relative mRNA levels were normalized to the 36B4 level. Data represent the mean 6 SEM (n=5 for each genotype). Asterisks indicate significant
differences (P,0.05). Data represent the means 6 SEM (n=5 for each genotype and point). (B) The liver was excised male control mice at the
indicated times. The open bar indicates the lights-on phase, and the dark bar indicates lights-off. The total RNA was extracted, and the expression of
Bmal1 and Lpl mRNA was determined as described in (A). Data represent the means 6 SEM (n=5 for each point). (C) The liver was excised from the
control mice housed in constant darkness for 10 days. The expression of Lpl mRNA was determined as described in (A). Data represent the means 6
SEM (n=5 for each point). (D) The liver was excised male control mice and L-Bmal1 -/- mice at the indicated times. The open bar indicates the lights-
on phase, and the dark bar indicates lights-off. The total RNA was extracted, and the expression of Lpl mRNA was determined as described in (A). Data
represent the means 6 SEM (n=5 for each genotype and point). Asterisks indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0025231.g007
Figure 8. A schematic diagram of Bmal1 deficiency-induced
abnormal lipid metabolism.
doi:10.1371/journal.pone.0025231.g008
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provide an excellent opportunity to gain new insights into the
regulation of energy homeostasis by BMAL1.
Materials and Methods
Animals
Conditional Bmal1 (flox/flox) mice, which carry the conditional
Bmal1 allele containing exons 6 to 8 flanked by loxP sites, were
generated using ES cells derived from C57BL/6J mice. Splicing of
exons 6 to 8 should cause a deletion of the bHLH domain and a
frameshift mutation with the introduction of an early stop codon
(TGA). Global (whole body) Bmal1 deficient (-/-) mice were
generated by breeding of Bmal1 (flox/flox) mice with knockin
C57BL/6J mice carrying the Cre recombinase gene driven by a
PGK promoter (Ozgene, Perth, Australia). Genotyping for exons
6–8 was performed by PCR on DNA isolated from tail biopsies by
using the forward primer A (59- GGGGATTTCCATCTGTG-
TTTAC-39) and primer B (59- CTCATCTGCTTATCTGCT-
CTGGGG -39). The Bmal1-excised allele amplified a 280-bp
band, whereas amplification from the Bmal1-unexcised allele
resulted in a 2500-bp band. Analysis of the excision of exon 8 was
carried out by PCR using primer C (59-CCTGGAACTCACT-
TTGTAGACC-39) and primer D (59- AACAGCCATCCTTAG-
CACG-39). A 250-bp band confirmed the presence of a gene
corresponding to exon 8. To obtain mice harboring liver or
skeletal muscle with excision at Bmal1, mice expressing the Bmal1
(flox/flox) allele were crossed to mice expressing a Cre transgene
driven by either the albumin (Alb) or the muscle creatine kinase
(Mck) promoter (Jackson Laboratories, Bar Harbor, ME). Mice
homozygous for the floxed allele and hemizygous for the Cre
transgene (Bmal1 (flox/flox/Cre
Alb)o rBmal1 (flox/flox/Cre
Mck))
were obtained by crossing Bmal1 (flox/+/Cre
Alb)o rBmal1 (flox/+/
Cre
Mck) mice to Bmal1 (flox/flox) mice. Littermates that were
negative for the Cre transgenes (Bmal1 (flox/flox)) were used as
experimental controls. All mice were maintained at 2361uC with
50610% relative humidity under a 12 h light/12 h dark cycle
(light: zeitgeber time (ZT) 0–12; dark; ZT12-24). For the
experiments under constant darkness (DD), mice were entrained
to DD condition for 7 days. All procedures during the dark period
were conducted using infrared vision and dim red lighting. Food
and water were available ad libitum. The high-fat diet consisted of
58% lard (wt/wt), 30% fish powder, 10% skim milk, and a 2%
vitamin and mineral mixture (equivalent to 7.5% carbohydrate,
24.5% protein, and 60% fat) (OYC, Tokyo, Japan). The regular
diet proportions were 54% carbohydrate, 20% protein, and 4.5%
fat (OYC). The experimental protocol was approved by the Ethics
Review Committee for Animal Experimentation of Nihon
University (Permit number:AP10P006).
Metabolic studies
Locomotor activity was measured by using an infrared passive
sensor system (Muromachi, Tokyo, Japan). Energy expenditure
was measured by an indirect calorimeter (Muromachi). For oral
glucose tolerance testing (OGTT), dextrose solution (2 g/kg body
weight) was administered by oral gavage. Glucose levels were
monitored before and at 15, 30, 60, and 120 min postgavage using
blood glucose strips (Arkray, Kyoto, Japan). Plasma insulin levels
during OGTT were measured by enzyme-linked immunosorbent
assay (MIoBS, Yokohama, Japan). Insulin tolerance tests were
performed by injecting 0.5 U insulin (Eli Lilly, Indianapolis, IN)/
kg body weight intraperitoneally, followed by blood collection at 0,
30, 60, 120, and 180 min after injection. Blood glucose values
were determined as described above.
Biochemical analysis of blood and tissue
Plasma lipoproteins were analyzed by an on-line dual enzymatic
method for simultaneous quantification of cholesterol and
triglycerides by HPLC at Skylight Biotech Inc. (Akita, Japan)
according to the procedure described by Usui et al. [46]. The
levels of serum TG, non-esterified fatty acid (NEFA), and total
cholesterol were determined using a commercially available
reagent (Wako, Tokyo, Japan). Hepatic and muscular lipids were
extracted according to the methods of Folch et al. [47]. The
extract was dissolved in 2-propanol and subsequently analyzed for
TG as described above.
Analysis of gene expression
Total RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. To
perform RT-qPCR, total RNA (1 mg) was reverse-transcribed
using oligo dT primers. A portion of the cDNA (corresponding to
0.04 mg of total RNA) was amplified on an MX3000P real-time
PCR system (Stratagene, La Jolla, CA) using Platinum SYBR
Green qPCR SuperMix-UDG (Invitrogen). Information on the
sequences of primers is available upon request. Standard curves
(R2.0.99) were generated using a serial dilution of cDNA, and
expression of all genes was normalized to the 36B4 level.
Supporting Information
Figure S1 Schematic diagram of the targeting construct
and the resulting mutant allele. Dotted lines represent the
fragment sizes generated by PCR genotyping of control and
mutant alleles.
(TIF)
Figure S2 Genotyping of Bmal1 -/- mice. PCR genotyping
of tail biopsies showing bands of 2500 bp and 280 bp indicating
the presence of the control and mutant alleles, respectively (Top).
The absence of 250 bp indicates deletion of exon 8 (bottom).
(TIF)
Figure S3 Representative activity records of individual
control mice and Bmal1 -/- mice. Animals were individually
housed under a light–dark (LD) cycle or constant darkness (DD).
The activity was measured by using an infrared passive sensor
system (Muromachi, Tokyo, Japan).
(TIF)
Figure S4 Comparison of gene expressions in adipose
tissues. Gene expressions in adipose tissues in control mice and
Bmal1 -/- mice at ZT10 and 22 were determined by RT-qPCR.
Relative mRNA levels were normalized to the 36B4 level. Data
represents the means 6 SEM (n=5 for each genotype and point).
Asterisks indicate significant differences (P,0.05).
(TIF)
Figure S5 Expression of Lpl mRNA in Bmal1-knock-
down cultured hepatocytes. Primary hepatocytes were
prepared from control mice and treated with siRNA solution
(controlandBmal1,finalconcentration100 nMeach)for48 h.The
total RNA was extracted from these cells, and the gene expression
was determined as described in Fig. 7A (n=4 for each treatment).
(TIF)
Figure S6 Representative images of control mice and
Bmal1 -/- mice fed a high-fat diet. Control mice and Bmal1
-/- mice were subjected to high-fat diet challenge for 3 days.
Excess sebum was observed only in Bmal1 -/- mice.
(TIF)
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experiments were performed at ZT10. (A, B) Male control mice
and Bmal1 -/- mice were fasted for 16 h. After oral glucose
administration (2 g/kg), the levels of blood glucose (A) and plasma
insulin (B) were monitored. Data represent the means 6 SEM
(n=8 for each genotype and point). Asterisks indicate significant
differences (P,0.05). (C) Male control mice and Bmal1 -/- mice
were fasted for 6 h. After i. p. injection of insulin (0.5 U/kg), blood
glucose levels were monitored. Data represent the means 6 SEM
(n=8 for each genotype and point). Asterisks indicate significant
differences (P,0.05). (D) Blood glucose levels in male control mice
and Bmal1 -/- mice fed ad libitum or fasted for 16 h are shown.
Data represent the means 6 SEM (n=8 for each genotype and
treatment). (E) The pancreas was isolated from male control mice
and Bmal1 -/- mice. Insulin contents in the tissues were
determined by ELISA. The values were corrected by the amount
of protein in the tissue. Data represent the means 6 SEM (n=8
for each genotype and point). Asterisks indicate significant
differences (P,0.05). (F) Response of male control mice and
Bmal1 -/- mice to i.p. injection of glibenclamide (2.5 mg/kg). Data
represent the means 6 SEM (n=8 for each genotype and point).
Asterisks indicate significant differences (P,0.05). (G) Represen-
tative morphology of islets stained with anti-insulin antibody. Scale
bars indicate 100 mm. (H) The average cross-sectional area of the
islets in Bmal1 -/- mice was compared with that in control mice.
Data represent the means 6 SEM (n=4 for each genotype and
point). Asterisks indicate significant differences (P,0.05).
(TIF)
Figure S8 Lowered gluconeogenesis activity in the
Bmal1 -/- mice liver. All experiments were performed at
ZT10. (A) Male control mice and Bmal1 -/- mice were fasted for
16 h. After i.p. injection of pyruvate (2 g/kg), blood glucose levels
were monitored. Data represent the means 6 SEM (n=8 for each
genotype and point). Asterisks indicate significant differences
(P,0.05). Gene expression levels in the liver of male control and
Bmal1 -/- mice were determined by RT-qPCR. Relative mRNA
levels were normalized to the 36B4 level. Data represent the
means 6 SEM (n=5 for each genotype). Asterisks indicate
significant differences (P,0.05). Levels of G6P and AMP in the
liver in male control and Bmal1 -/- mice were determined by
capillary electrophoresis time-of-flight mass spectrometry. Data
represent the means 6 SEM (n=4 for each genotype). Asterisks
indicate significant differences (P,0.05).
(TIF)
Figure S9 Phosphorylation status of HSL in Bmal1 -/-
mice adipose tissue. Total HSL protein level and phosphor-
ylated form of HSL protein in the adipose tissue isolated from
male control mice and Bmal1 -/- mice at ZT10 were determined
by Western blot.
(TIF)
Table S1 Gene expressions in Bmal1 -/- mice. Gene
expressions in control mice and Bmal1 -/- mice were determined
by RT-qPCR. Relative mRNA levels were normalized to the
36B4level. N.D. not determined. Each value represented the mean
fold-changes (6 SEM) of Bmal1 -/- mice in comparison to control
mice (n=5 for each genotype and point). Asterisks indicate
significant differences (P,0.05).
(DOC)
Text S1 Impaired glucose deposition and acceleration
of gluconeogenesis in Bmal1 -/- mice.
(DOC)
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